Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.

Huynh, Hung

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. [electronic resource] - Journal of hepatology Jul 2008 - 52-60 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0168-8278

10.1016/j.jhep.2008.02.022 doi


Angiogenesis Inhibitors--pharmacology
Animals
Antibiotics, Antineoplastic--pharmacology
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Hepatocellular--drug therapy
Disease Models, Animal
Drug Therapy, Combination
Liver Neoplasms--drug therapy
Mechanistic Target of Rapamycin Complex 1
Mice
Mice, SCID
Multiprotein Complexes
Proteins
Signal Transduction--drug effects
Sirolimus--pharmacology
Survival Rate
TOR Serine-Threonine Kinases
Transcription Factors--metabolism
Vascular Endothelial Growth Factor A--metabolism
Xenograft Model Antitumor Assays